معرفی
Jifeng Zhang serves as a Research Professor in the Department of Internal Medicine - Cardiology at the University of Michigan Medical School. His work focuses on cardiovascular research with particular emphasis on atherosclerosis, vascular biology, and metabolic diseases.
Dr. Zhang's research interests span multiple areas of cardiovascular medicine and metabolic disorders:
- Atherosclerosis development and treatment
- Vascular calcification mechanisms
- Abdominal and thoracic aortic aneurysm pathophysiology
- Lipid metabolism and its impact on cardiovascular health
- Cardiovascular complications of metabolic dysfunction-associated steatohepatitis (MASH)
- Gene editing applications in cardiovascular research
- Circadian regulation of blood pressure
His recent publication record demonstrates a strong focus on translational cardiovascular research, with particular emphasis on developing novel therapeutic approaches for atherosclerosis and vascular diseases. His work on the tripeptide DT-109 for treating atherosclerosis and fatty liver disease represents a significant advancement in dual-therapy approaches for cardiovascular and metabolic conditions. His research also spans gene editing technologies, as evidenced by his contribution to the EXPERT system for prime editing.
Dr. Zhang's research is highly collaborative, working with teams across multiple institutions to advance understanding of vascular pathologies and develop innovative treatments for cardiovascular diseases.
